We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
676

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BYSI icon
3551
BeyondSpring
BYSI
$34.5M
$22K ﹤0.01%
5,024
-8,422
-63% -$95.1K
CMCO icon
3552
Columbus McKinnon
CMCO
$556M
$22K ﹤0.01%
483
-800
-62% -$38.6K
COOP
3553
DELISTED
Mr. Cooper
COOP
$22K ﹤0.01%
536
-8,121
-94% -$342K
CREX icon
3554
Creative Realities
CREX
$43M
$22K ﹤0.01%
5,167
+4,785
+1,253% +$22.6K
CRVL icon
3555
CorVel
CRVL
$3.32B
$22K ﹤0.01%
312
-147
-32% -$9.23K
CSTE icon
3556
Caesarstone
CSTE
$119M
$22K ﹤0.01%
1,980
+566
+40% +$6.79K
CTRN icon
3557
Citi Trends
CTRN
$616M
$22K ﹤0.01%
226
-357
-61% -$28.5K
DBE icon
3558
Invesco DB Energy Fund
DBE
$91.1M
$22K ﹤0.01%
1,289
+289
+29% +$5.04K
EPC icon
3559
Edgewell Personal Care
EPC
$1.31B
$22K ﹤0.01%
473
-10,224
-96% -$413K
FBNC icon
3560
First Bancorp
FBNC
$2.74B
$22K ﹤0.01%
485
-7,654
-94% -$359K
FTEK icon
3561
Fuel Tech
FTEK
$45.3M
$22K ﹤0.01%
15,241
+15,150
+16,648% +$26.7K
GLSI icon
3562
Greenwich LifeSciences
GLSI
$247M
$22K ﹤0.01%
896
+649
+263% +$21.7K
IMA
3563
ImageneBio Inc
IMA
$66.3M
$22K ﹤0.01%
146
+84
+135% +$13.6K
NUVB icon
3564
Nuvation Bio
NUVB
$2.18B
$22K ﹤0.01%
2,588
-1,110
-30% -$10.2K
TEAD
3565
Teads Holding Co
TEAD
$66.8M
$22K ﹤0.01%
1,535
+932
+155% +$14.4K
OFIX icon
3566
Orthofix Medical
OFIX
$421M
$22K ﹤0.01%
679
-735
-52% -$24.6K
OPRT icon
3567
Oportun Financial
OPRT
$355M
$22K ﹤0.01%
1,078
+445
+70% +$10.4K
PECO icon
3568
Phillips Edison & Co
PECO
$5.21B
$22K ﹤0.01%
657
-102
-13% -$3.27K
PLRX icon
3569
Pliant Therapeutics
PLRX
$66.3M
$22K ﹤0.01%
1,630
+923
+131% +$14.7K
SCHV
3570
Schwab US Large-Cap Value ETF
SCHV
$16.3B
$22K ﹤0.01%
909
-17,682
-95% -$419K
UAVS icon
3571
AgEagle Aerial Systems
UAVS
$63.9M
$22K ﹤0.01%
14
+12
+600% +$29.1K
VONG icon
3572
Vanguard Russell 1000 Growth ETF
VONG
$46.1B
$22K ﹤0.01%
285
-7,580
-96% -$578K
WABC icon
3573
Westamerica Bancorp
WABC
$1.38B
$22K ﹤0.01%
387
-1,058
-73% -$59.6K
YANG icon
3574
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.1M
$22K ﹤0.01%
53
+8
+18% +$2.88K
ZDGE icon
3575
Zedge
ZDGE
$38.4M
$22K ﹤0.01%
2,683
+668
+33% +$7.32K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 676 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.